With the development of novel bio-therapeutic antibody formats, such as trifunctional and bispecific monoclonal antibodies or antibody fragments, new purification challenges in the downstream process of these molecules arise.

Complete the form to download this poster to learn more about how antibody sub-domain specific affinity products provide high target purity in a single step, independent of feedstock.

(*Indicates a mandatory field)